130 related articles for article (PubMed ID: 36083158)
1. Use of Prospective Multiplex Immunohistochemistry to Redefine Tissue Pathways of Diagnostic Core Biopsy of Prostate.
Thomas T; Wedden S; Afzal N; Mikel J; D'Arrigo C
Appl Immunohistochem Mol Morphol; 2022 Oct; 30(9):585-591. PubMed ID: 36083158
[TBL] [Abstract][Full Text] [Related]
2. Virtual microscopy in prostate histopathology: simultaneous viewing of biopsies stained sequentially with hematoxylin and eosin, and alpha-methylacyl-coenzyme A racemase/p63 immunohistochemistry.
Helin HO; Lundin ME; Laakso M; Lundin J; Helin HJ; Isola J
J Urol; 2006 Feb; 175(2):495-9. PubMed ID: 16406979
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
Browne TJ; Hirsch MS; Brodsky G; Welch WR; Loda MF; Rubin MA
Hum Pathol; 2004 Dec; 35(12):1462-8. PubMed ID: 15619204
[TBL] [Abstract][Full Text] [Related]
4. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?
Zhou M; Aydin H; Kanane H; Epstein JI
Am J Surg Pathol; 2004 Feb; 28(2):239-43. PubMed ID: 15043314
[TBL] [Abstract][Full Text] [Related]
5. Utility of immunohistochemistry markers in the interpretation of post-high-intensive focussed ultrasound prostate biopsy cores.
Walter B; Weiss T; Hofstädter F; Gaumann A; Hartmann A; Rogenhofer S; Ganzer R; Wach S; Engehausen D; Wieland WF; Blana A
World J Urol; 2013 Oct; 31(5):1129-33. PubMed ID: 22350516
[TBL] [Abstract][Full Text] [Related]
6. Signature maps for automatic identification of prostate cancer from colorimetric analysis of H&E- and IHC-stained histopathological specimens.
Leng E; Henriksen JC; Rizzardi AE; Jin J; Nam JW; Brassuer BM; Johnson AD; Reder NP; Koopmeiners JS; Schmechel SC; Metzger GJ
Sci Rep; 2019 May; 9(1):6992. PubMed ID: 31061447
[TBL] [Abstract][Full Text] [Related]
7. Significance of prostate cancer missed on needle biopsy tools for retrieving missed cancer.
Bonkhoff H
Prostate; 2016 Mar; 76(4):369-75. PubMed ID: 26616257
[TBL] [Abstract][Full Text] [Related]
8. Determination of Optimum Formalin Fixation Duration for Prostate Needle Biopsies for Immunohistochemistry and Quantum Dot FISH Analysis.
Sathyanarayana UG; Birch C; Nagle RB; Tomlins SA; Palanisamy N; Zhang W; Hubbard A; Brunhoeber P; Wang Y; Tang L
Appl Immunohistochem Mol Morphol; 2015; 23(5):364-73. PubMed ID: 25265431
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues.
Hameed O; Sublett J; Humphrey PA
Am J Surg Pathol; 2005 May; 29(5):579-87. PubMed ID: 15832080
[TBL] [Abstract][Full Text] [Related]
10. Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue.
Andrews C; Humphrey PA
Am J Surg Pathol; 2014 Jul; 38(7):1007-12. PubMed ID: 24705308
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostates.
Olivier J; Stavrinides V; Kay J; Freeman A; Pye H; Ahmed Z; Carmona Echeverria L; Heavey S; Simmons LAM; Kanthabalan A; Arya M; Briggs T; Barratt D; Charman SC; Gelister J; Hawkes D; Hu Y; Jameson C; McCartan N; Punwani S; van der Muelen J; Moore C; Emberton M; Ahmed HU; Whitaker HC
Prostate; 2018 Dec; 78(16):1229-1237. PubMed ID: 30073682
[TBL] [Abstract][Full Text] [Related]
12. Hematoxylin and Eosin Counterstaining Protocol for Immunohistochemistry Interpretation and Diagnosis.
Grosset AA; Loayza-Vega K; Adam-Granger É; Birlea M; Gilks B; Nguyen B; Soucy G; Tran-Thanh D; Albadine R; Trudel D
Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):558-563. PubMed ID: 29271792
[TBL] [Abstract][Full Text] [Related]
13. Use of Deep Learning to Develop and Analyze Computational Hematoxylin and Eosin Staining of Prostate Core Biopsy Images for Tumor Diagnosis.
Rana A; Lowe A; Lithgow M; Horback K; Janovitz T; Da Silva A; Tsai H; Shanmugam V; Bayat A; Shah P
JAMA Netw Open; 2020 May; 3(5):e205111. PubMed ID: 32432709
[TBL] [Abstract][Full Text] [Related]
14. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.
Warrick JI; Humphrey PA
Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726
[TBL] [Abstract][Full Text] [Related]
15. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies.
Beach R; Gown AM; De Peralta-Venturina MN; Folpe AL; Yaziji H; Salles PG; Grignon DJ; Fanger GR; Amin MB
Am J Surg Pathol; 2002 Dec; 26(12):1588-96. PubMed ID: 12459625
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic use of ERG in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers.
Shah RB; Tadros Y; Brummell B; Zhou M
Hum Pathol; 2013 May; 44(5):786-94. PubMed ID: 23158212
[TBL] [Abstract][Full Text] [Related]
17. Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy.
Carswell BM; Woda BA; Wang X; Li C; Dresser K; Jiang Z
Histopathology; 2006 May; 48(6):668-73. PubMed ID: 16681682
[TBL] [Abstract][Full Text] [Related]
18. Routine dual-color immunostaining with a 3-antibody cocktail improves the detection of small cancers in prostate needle biopsies.
Tolonen TT; Kujala PM; Laurila M; Tirkkonen M; Ilvesaro J; Tuominen VJ; Tammela TL; Isola J
Hum Pathol; 2011 Nov; 42(11):1635-42. PubMed ID: 21497369
[TBL] [Abstract][Full Text] [Related]
19. Routine Hematoxylin and Eosin Stain Is Specific for the Diagnosis of Cytomegalovirus Infection in Gastrointestinal Biopsy Specimens.
Guo L; DeRoche TC; Salih ZT; Qasem SA
Int J Surg Pathol; 2018 Sep; 26(6):500-506. PubMed ID: 29532684
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy.
Epstein JI
Mod Pathol; 2004 Mar; 17(3):307-15. PubMed ID: 14739905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
